National Oilwell Varco, Inc. (NYSE:NOV) shares moved down -1.24% in last trading session and ended the day at $36.59. NOV Gross Margin is 23.90% and its has a return on assets of 4.30%. National Oilwell Varco, Inc. (NYSE:NOV) quarterly performance is -7.35%.
National Oilwell Varco, Inc. (NYSE:NOV) declared a quarterly dividend. Stockholders of record on Friday, December 4th will be given a dividend of 0.46 per share by the oil and gas exploration company on Friday, December 18th. This represents a $1.84 annualized dividend and a dividend yield of 4.83%. The ex-dividend date is Wednesday, December 2nd.
Alliqua Biomedical Inc (NASDAQ:ALQA) ended the last trading day at $2.45. Company weekly volatility is calculated as 5.49% and price to cash ratio as 2.21. Alliqua Biomedical Inc (NASDAQ:ALQA) showed a weekly performance of -7.20%.
Alliqua Biomedical Inc (NASDAQ:ALQA) had its price objective reduced by Chardan Capital from $8.00 to $4.25 in a research note issued to investors on Friday,MarketBeat.Com reports. Chardan Capital currently has a buy rating on the stock.
NCI, Inc. (NASDAQ:NCIT) shares increased 3.39% in last trading session and ended the day at $16.47. NCIT Gross Margin is 16.30% and its has a return on assets of 7.00%. NCI, Inc. (NASDAQ:NCIT) quarterly performance is 6.33%.
On 27 November, NCI, Inc. (NASDAQ:NCIT) said that, its board member Paul Lombardi was inducted into the Greater Washington Government Contractor Awards Hall of Fame. He was recognized as this year’s Hall of Fame honoree for unparalleled professional excellence and life-long contributions to the community and government contracting industry.
Curis, Inc. (NASDAQ:CRIS) shares moved up 4.38% in last trading session and ended the day at $2.86. CRIS Gross Margin is 94.90% and its has a return on assets of -51.20%. Curis, Inc. (NASDAQ:CRIS) quarterly performance is 13.49%.
Curis, Inc. (NASDAQ:CRIS) presented data from the completed dose escalation and ongoing expansion stages of the Phase 1 trial of CUDC-907, an oral dual inhibitor of histone deacetylase or HDAC and phosphoinositide 3-kinase or PI3K enzymes.
American Eagle Outfitters, Inc. (NYSE:AEO) caters to the Services space. It has a net profit margin of 3.90% and weekly performance is -3.66%. On the last day of trading company shares ended up at $15.80. American Eagle Outfitters, Inc. (NYSE:AEO) distance from 50-day simple moving average (SMA50) is 0.89%.
On 2 December, American Eagle Outfitters, Inc. (NYSE:AEO) reported fiscal third-quarter profit of $74.1 million, or 38 cents a share. Earnings, adjusted to account for discontinued operations, came to 35 cents per share.
Leave a Reply